- Home
- ANGO vs ZBIO Comparison
ANGO vs ZBIO Comparison
Compare ANGO & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- ZBIO
- Stock Information
- Founded
- ANGO 1988
- ZBIO 2019
- Country
- ANGO United States
- ZBIO United States
- Employees
- ANGO N/A
- ZBIO N/A
- Industry
- ANGO Medical/Dental Instruments
- ZBIO
- Sector
- ANGO Health Care
- ZBIO
- Exchange
- ANGO Nasdaq
- ZBIO NYSE
- Market Cap
- ANGO 279.1M
- ZBIO 268.7M
- IPO Year
- ANGO 2004
- ZBIO 2024
- Fundamental
- Price
- ANGO $9.92
- ZBIO $8.33
- Analyst Decision
- ANGO Strong Buy
- ZBIO Strong Buy
- Analyst Count
- ANGO 3
- ZBIO 6
- Target Price
- ANGO $13.00
- ZBIO $31.83
- AVG Volume (30 Days)
- ANGO 511.4K
- ZBIO 129.7K
- Earning Date
- ANGO 04-02-2025
- ZBIO 05-16-2025
- Dividend Yield
- ANGO N/A
- ZBIO N/A
- EPS Growth
- ANGO N/A
- ZBIO N/A
- EPS
- ANGO N/A
- ZBIO N/A
- Revenue
- ANGO $286,498,000.00
- ZBIO $5,000,000.00
- Revenue This Year
- ANGO N/A
- ZBIO N/A
- Revenue Next Year
- ANGO $6.63
- ZBIO N/A
- P/E Ratio
- ANGO N/A
- ZBIO N/A
- Revenue Growth
- ANGO N/A
- ZBIO N/A
- 52 Week Low
- ANGO $5.26
- ZBIO $5.83
- 52 Week High
- ANGO $13.50
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- ANGO 52.71
- ZBIO N/A
- Support Level
- ANGO $9.34
- ZBIO N/A
- Resistance Level
- ANGO $9.84
- ZBIO N/A
- Average True Range (ATR)
- ANGO 0.47
- ZBIO 0.00
- MACD
- ANGO 0.13
- ZBIO 0.00
- Stochastic Oscillator
- ANGO 95.94
- ZBIO 0.00
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.